IMRA Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 37.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $619,058.41
IMARA Share Price & Price History
Current Price: $47.05
Price Change: ▼ Price Decrease of -0.7617 (-1.59%)
As of 05/29/2025 01:00 AM ET
IMARA Insider Trading History
IMARA Institutional Trading History
Data available starting January 2016
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Read More on IMARA
Today's Range
Now: $47.05
52 Week Range
Now: $47.05
Volume
21,639 shs
Average Volume
138,364 shs
Market Capitalization
$1.23 billion
P/E Ratio
941.28
Dividend Yield
N/A
Beta
1.09
Who are the company insiders with the largest holdings of IMARA?